Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Eye Drops & Ophthalmic Recalls

Recalls of ophthalmic solutions and eye drops - a category hit by widely reported contamination recalls.

673 recalls in this category, newest first.

Class III · Low risk

Ciprofloxacin Ophthalmic Solution

Failed Impurities/Degradation Specifications: Firm voluntarily recalled products due to out-of-specification results for an unknown impurity at or near the expiration (24-month).

Terminated Impurity / degradation Actavis Pharma Inc D-1060-2016
Class II · Moderate risk

TEARS Naturale FREE

Lack of Assurance of Sterility: Some single-use vials may be filled with water rather than the product solution and the firm cannot guarantee the sterility of the water-filled vials.

Terminated Sterility / contamination Alcon Research, Ltd. D-0666-2016
Class II · Moderate risk

Voriconazole Solution

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-2815-10 D-0293-2016
Class II · Moderate risk

Vancomycin Ophthalmic PF 0.5 mL

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-0209-64 D-0291-2016
Class II · Moderate risk

Tropicamide 1%/Phenylephrine 2.5%

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3214-07 D-0290-2016
Class II · Moderate risk

Tropicamide 0.5%/ Phenylephrine 5%

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3298-02 D-0289-2016
Class II · Moderate risk

Pilocarpine

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc D-0278-2016
Class II · Moderate risk

Phenylephrine PF Sterile Solution

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3272-03 D-0277-2016
Class II · Moderate risk

Phenylephrine 10% PF Ophthalmic Solution

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3273-03 D-0274-2016
Class II · Moderate risk

Dapiprazole

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-0201-99 D-0247-2016
Class II · Moderate risk

Cyclopent/PE/Tropic 2mL

Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance.

Terminated Sterility / contamination US Compounding Inc NDC 62295-3299-02 D-0246-2016